135 related articles for article (PubMed ID: 15107012)
1. Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor.
Joët T; Chotivanich K; Silamut K; Patel AP; Morin C; Krishna S
Biochem J; 2004 Aug; 381(Pt 3):905-9. PubMed ID: 15107012
[TBL] [Abstract][Full Text] [Related]
2. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
Joet T; Eckstein-Ludwig U; Morin C; Krishna S
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024
[TBL] [Abstract][Full Text] [Related]
3. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
[TBL] [Abstract][Full Text] [Related]
4. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family.
Joët T; Holterman L; Stedman TT; Kocken CH; Van Der Wel A; Thomas AW; Krishna S
Biochem J; 2002 Dec; 368(Pt 3):923-9. PubMed ID: 12238947
[TBL] [Abstract][Full Text] [Related]
5. Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT).
Ionita M; Krishna S; Léo PM; Morin C; Patel AP
Bioorg Med Chem Lett; 2007 Sep; 17(17):4934-7. PubMed ID: 17587575
[TBL] [Abstract][Full Text] [Related]
6. Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives.
Fayolle M; Ionita M; Krishna S; Morin C; Patel AP
Bioorg Med Chem Lett; 2006 Mar; 16(5):1267-71. PubMed ID: 16361099
[TBL] [Abstract][Full Text] [Related]
7. Structure-function analysis of liver-type (GLUT2) and brain-type (GLUT3) glucose transporters: expression of chimeric transporters in Xenopus oocytes suggests an important role for putative transmembrane helix 7 in determining substrate selectivity.
Arbuckle MI; Kane S; Porter LM; Seatter MJ; Gould GW
Biochemistry; 1996 Dec; 35(51):16519-27. PubMed ID: 8987985
[TBL] [Abstract][Full Text] [Related]
8. QLS motif in transmembrane helix VII of the glucose transporter family interacts with the C-1 position of D-glucose and is involved in substrate selection at the exofacial binding site.
Seatter MJ; De la Rue SA; Porter LM; Gould GW
Biochemistry; 1998 Feb; 37(5):1322-6. PubMed ID: 9477959
[TBL] [Abstract][Full Text] [Related]
9. The hexose transporter of Plasmodium falciparum is a worthy drug target.
Joët T; Krishna S
Acta Trop; 2004 Feb; 89(3):371-4. PubMed ID: 14744563
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the hexose transporter of Plasmodium falciparum and development of a three-dimensional model.
Manning SK; Woodrow C; Zuniga FA; Iserovich P; Fischbarg J; Louw AI; Krishna S
J Biol Chem; 2002 Aug; 277(34):30942-9. PubMed ID: 12042321
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterisation of the Plasmodium vivax rhoptry-associated protein 2.
Patarroyo MA; Perez-Leal O; Lopez Y; Cortes J; Rojas-Caraballo J; Gomez A; Moncada C; Rosas J; Patarroyo ME
Biochem Biophys Res Commun; 2005 Nov; 337(3):853-9. PubMed ID: 16214111
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
[TBL] [Abstract][Full Text] [Related]
13. Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes.
Woodrow CJ; Burchmore RJ; Krishna S
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9931-6. PubMed ID: 10954735
[TBL] [Abstract][Full Text] [Related]
14. Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering.
Heitmeier MR; Hresko RC; Edwards RL; Prinsen MJ; Ilagan MXG; Odom John AR; Hruz PW
PLoS One; 2019; 14(5):e0216457. PubMed ID: 31071153
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of
Won JY; Mazigo E; Cha SH; Han JH
Front Cell Infect Microbiol; 2023; 13():1321240. PubMed ID: 38282613
[No Abstract] [Full Text] [Related]
16. Docking, QM/MM, and molecular dynamics simulations of the hexose transporter from Plasmodium falciparum (PfHT).
Fonseca AL; Nunes RR; Braga VM; Comar M; Alves RJ; Varotti Fde P; Taranto AG
J Mol Graph Model; 2016 May; 66():174-86. PubMed ID: 27131282
[TBL] [Abstract][Full Text] [Related]
17. Identification, expression and characterisation of a Babesia bovis hexose transporter.
Derbyshire ET; Franssen FJ; de Vries E; Morin C; Woodrow CJ; Krishna S; Staines HM
Mol Biochem Parasitol; 2008 Oct; 161(2):124-9. PubMed ID: 18638508
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of pvcrt-o, a Plasmodium vivax ortholog of pfcrt, in Plasmodium falciparum and Dictyostelium discoideum.
Sá JM; Yamamoto MM; Fernandez-Becerra C; de Azevedo MF; Papakrivos J; Naudé B; Wellems TE; Del Portillo HA
Mol Biochem Parasitol; 2006 Dec; 150(2):219-28. PubMed ID: 16987557
[TBL] [Abstract][Full Text] [Related]
19. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
Ellekvist P; Colding H
Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
[TBL] [Abstract][Full Text] [Related]
20. Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds.
Ortiz D; Guiguemde WA; Johnson A; Elya C; Anderson J; Clark J; Connelly M; Yang L; Min J; Sato Y; Guy RK; Landfear SM
PLoS One; 2015; 10(4):e0123598. PubMed ID: 25894322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
